• myGriffith
    • Staff portal
    • Contact Us⌄
      • Future student enquiries 1800 677 728
      • Current student enquiries 1800 154 055
      • International enquiries +61 7 3735 6425
      • General enquiries 07 3735 7111
      • Online enquiries
      • Staff phonebook
    View Item 
    •   Home
    • Griffith Theses
    • Theses - Higher Degree by Research
    • View Item
    • Home
    • Griffith Theses
    • Theses - Higher Degree by Research
    • View Item
    JavaScript is disabled for your browser. Some features of this site may not work without it.

    Browse

  • All of Griffith Research Online
    • Communities & Collections
    • Authors
    • By Issue Date
    • Titles
  • This Collection
    • Authors
    • By Issue Date
    • Titles
  • Statistics

  • Most Popular Items
  • Statistics by Country
  • Most Popular Authors
  • Support

  • Contact us
  • FAQs
  • Admin login

  • Login
  • Screening Clinically Relevant Biomarkers in Cancer

    Thumbnail
    View/Open
    Haque_2017_01Thesis.pdf (9.307Mb)
    Author
    Haque, Md. Hakimul
    Primary Supervisor
    Alfred Lam
    Vinod Gopalan
    Other Supervisors
    Robert Smith
    Muhammad Shiddiky
    Year published
    2017
    Metadata
    Show full item record
    Abstract
    Oesophageal carcinoma is one of the most aggressive malignancies and the sixth leading cause of cancer-associated mortality worldwide. Being the most prevalent histological subtype, oesophageal squamous cell carcinoma (ESCC) accounts for approximately 90% of oesophageal cancer cases. Both genetic and epigenetic alterations contribute to the pathogenesis of ESCC along with considerable diversity in clinical behaviour and prognosis. In-depth biochemical research on rapid profiling and quantification of potential biomarkers are crucial in the clinical management of patients with cancer for developing effective diagnostic tools ...
    View more >
    Oesophageal carcinoma is one of the most aggressive malignancies and the sixth leading cause of cancer-associated mortality worldwide. Being the most prevalent histological subtype, oesophageal squamous cell carcinoma (ESCC) accounts for approximately 90% of oesophageal cancer cases. Both genetic and epigenetic alterations contribute to the pathogenesis of ESCC along with considerable diversity in clinical behaviour and prognosis. In-depth biochemical research on rapid profiling and quantification of potential biomarkers are crucial in the clinical management of patients with cancer for developing effective diagnostic tools along with the accurate prediction of prognosis and therapy response in cancer. Currently, there are many conventional and nanotechnological approaches for screening clinically relevant various genetic and epigenetic biomarkers such as point mutation, DNA methylation, global methylation for the early diagnosis and management of ESCC, resulting in a 10% five-year survival rate for patients. Despite excellent analytical performances of the existing detection methodologies, electrochemical approaches offer a promising alternative for simple, sensitive, specific, rapid, and cost-effective analysis of genetic and epigenetic biomarkers in cancer samples. Therefore, innovative technology using electrochemical approach would be an effective way for the detection of biomarkers in patients with cancer.
    View less >
    Thesis Type
    Thesis (PhD Doctorate)
    Degree Program
    Doctor of Philosophy (PhD)
    School
    School of Medical Science
    Item Access Status
    Restricted (for period of time)
    Subject
    Oesophageal carcinoma
    Oesophageal squamous cell carcinoma (ESCC)
    DNA methylation
    Global methylation
    Cancer screening
    Publication URI
    http://hdl.handle.net/10072/367911
    Collection
    • Theses - Higher Degree by Research

    Footer

    Social media

    • Facebook
    • Twitter
    • YouTube
    • Instagram
    • Linkedin
    First peoples of Australia
    • Aboriginal
    • Torres Strait Islander

    Disclaimer

    • Privacy policy
    • Copyright matters
    • CRICOS Provider - 00233E

    Tagline

    • Gold Coast
    • Logan
    • Brisbane
    • Australia